Commodity Supercycl...
Health Care: Drugs
Novogen Ltd. (NVGN: NASDAQ)
$3.92 -0.11 | -2.73%
05/22/13 - 03:58 PM ET
Company Balance Sheet
| Jun 2012 | Jun 2011 | Jun 2010 | Jun 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 8.55M | 6.80M | 12.86M | 26.91M |
| Receivables | 413.74K | 5.32M | 1.69M | 1.82M |
| Inventories | 0.00 | 698.97K | 1.33M | 1.08M |
| Other Current Assets | 0.00 | 706.45K | 375.64K | 455.98K |
| Total Current Assets | 9.17M | 13.53M | 16.25M | 30.26M |
| Property, Plant & Equipment, Gross | 106.51K | 783.40K | 2.30M | 2.26M |
| Accumulated Depreciation & Depletion | 78.86K | 711.80K | 2.16M | 1.98M |
| Property, Plant & Equipment, Net | 27.65K | 71.61K | 146.18K | 284.89K |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Assets | 27.65K | 71.61K | 146.18K | 284.89K |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 9.20M | 13.60M | 16.39M | 30.54M |
| Accounts Payable | 851.02K | 2.07M | 4.56M | 6.50M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 194.58K | 1.94M | 507.37K | 624.66K |
| Total Current Liabilities | 3.96M | 8.77M | 5.07M | 7.13M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 7.17K | 111.15K | 129.18K | 190.46K |
| Minority Interest | -2.72M | -3.19M | -2.47M | -3.92M |
| Total Non-Current Liabilities | 1.68M | 315.28K | 1.82M | 4.30M |
| Total Liabilities | 5.64M | 9.08M | 6.88M | 11.43M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 3.56M | 4.52M | 9.51M | 19.11M |
| Common Par | 203.82M | 207.66M | 175.43M | 166.59M |
| Additional Paid In Capital | 0.00 | 0.00 | 0.00 | 0.00 |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -196.32M | -199.48M | -165.92M | -145.05M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -3.94M | -3.66M | 0.00 | -2.43M |
| Total Capitalization | 3.56M | 4.52M | 9.51M | 19.11M |
| Total Equity | 3.56M | 4.52M | 9.51M | 19.11M |
| Total Liabilities & Stock Equity | 9.20M | 13.60M | 16.39M | 30.54M |
| Total Common Shares Outstanding | 4.15M | 4.09M | 4.09M | 4.09M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 4.10M | 4.09M | 3.89M | 4.07M |
| Diluted Weighted Shares Outstanding | 4.10M | 4.09M | 3.89M | 4.07M |
| Number of Employees | 13 | 21 | 37 | 48 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with NVGN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserSUPRATRADE HOT STOCKS (BUY ...
- UserSUPRATRADE HOT STOCKS (BUY ...
- User©SUPRATRADE HOT STOCKS (...
- Userscjs4r speculative
Latest NVGN Headlines from TheStreet
- 5 Stocks Poised to Break Out 05.10.13 | 02:05 pm
- Tiny Biotechs Dancing in the Bull Pen 05.20.09 | 12:05 pm
- Monday's Health Winners & Losers 09.18.06 | 03:09 pm
- Friday's Health Winners & Losers 08.25.06 | 03:08 pm
- Health Stocks in Motion 07.06.04 | 05:07 pm
Press Releases for NVGN
- As Released On 30 December, 2011: Novogen Modifies ADR Program And Makes Further Investment Into Marshall Edwards - PR Newswire 01.04.12 | 05:01 pm
- Glycotex, Inc. Awarded Cash Grant Under The U.S. Government Qualifying Therapeutic Discovery Program - PR Newswire 11.24.10 | 08:11 am
- Marshall Edwards Reaches Agreement In Principle To Acquire Intellectual Property Portfolio From Novogen - PR Newswire 09.08.10 | 08:09 am
- Marshall Edwards To Host Conference Call On September 8, 2010 - PR Newswire 08.31.10 | 09:08 am
- Marshall Edwards Appoints Oncologist Christine White To Board Of Directors - PR Newswire 08.10.10 | 07:08 am
Partner Headlines for NVGN
- Morning Market Movers - Benzinga 04.03.13 | 09:04 am
- On January 3rd, Novogen to Change ADR Conversion Ratio, Similar to a 5:1 Reverse Stock Split - Benzinga 12.29.11 | 01:12 pm
- Top Buy and Sell Ideas Based on Wednesday's Biggest Gainers - Seeking Alpha 07.28.11 | 09:07 am
